已收录 268921 条政策
 政策提纲
  • 暂无提纲
Vitamin D Metabolism in Osteogenesis Imperfecta During Calcitonin Therapy
[摘要] The effect of calcitonin on plasma concentrations of 25-hydroxyvitamin D (25-OHD) and 1,25-dihydroxyvitamin D [1,25-(OH)2D] was studied in six patients with osteogenesis imperfecta. The mean pretreatment value of plasma 1,25-(OH)2D was significantly higher than the mean value of age-matched control subjects ( P < .05). High or normal plasma levels of 1,25-(OH)2D before calcitonin therapy were decreased after 1 month of therapy and remained normal thereafter in all six patients. Plasma 25-hydroxyvitamin D concentrations, which were normal before calcitonin injection, remained normal during calcitonin administration. These results indicate that there may be acute and chronic effects of calcitonin on vitamin D metabolism.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 儿科学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文